Synergistic Tissue Ablation Systems using AI, IoT, and Novel Materials
Legal Citation
Summary of the Inventive Concept
The inventive concept integrates AI-driven pulse shape design, IoT-enabled ablation devices, and novel materials with enhanced electro-osmotic diffusion properties to create a more powerful and efficient tissue ablation system, offering improved treatment outcomes and reduced complications.
Background and Problem Solved
The original patent disclosed methods, systems, and apparatuses for tissue ablation using pulse shape designs. However, these approaches have limitations, such as the need for manual optimization of pulse shape designs and the potential for electric discharge of gases during treatment. The new inventive concept addresses these limitations by incorporating AI-driven optimization, IoT-enabled real-time monitoring, and novel materials to create a more synergistic and effective tissue ablation system.
Detailed Description of the Inventive Concept
The inventive concept comprises an AI-driven pulse shape design module that integrates with an IoT-enabled ablation device. The AI module optimizes pulse shape designs for synergistic electroporation and electrolysis effects, reducing the need for manual optimization. The IoT-enabled device enables real-time monitoring and data exchange between the device and a cloud-based server, facilitating personalized treatment planning and adaptive tissue ablation. Additionally, the incorporation of novel materials with enhanced electro-osmotic diffusion properties further enhances the system's efficiency and effectiveness. The system can be used for various tissue ablation applications, including cancer treatment and cosmetic procedures.
Novelty and Inventive Step
The new claims introduce the novel combination of AI-driven pulse shape design, IoT-enabled ablation devices, and novel materials, which provides a synergistic effect that is not obvious from the original patent. The integration of these distinct technologies enables a more powerful and efficient tissue ablation system that was not anticipated by the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept may include the use of blockchain-secured data storage for enhanced data security, or the incorporation of other novel materials with different properties. Variations of the system may be designed for specific tissue ablation applications, such as cardiac ablation or ophthalmic treatments.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the medical device industry, particularly in the areas of cancer treatment, cosmetic procedures, and minimally invasive surgeries. The system's ability to provide improved treatment outcomes and reduced complications makes it an attractive solution for hospitals, clinics, and medical research institutions.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61B18/1206 |
| A | A61 | A61B18/1402 |
| A | A61 | A61N1/205 |
| A | A61 | A61N1/327 |
| A | A61 | A61B5/14539 |
| A | A61 | A61B2018/00577 |
| A | A61 | A61B2018/00613 |
| A | A61 | A61B2018/00827 |
| A | A61 | A61B2018/00994 |
| A | A61 | A61B2018/1266 |
| A | A61 | A61B2018/1472 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biomedical engineering, specifically electrosurgical and tissue ablation technologies involving pulse-based electrical interventions, with expertise in electroporation, device control systems, and advanced signal processing
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device researcher with advanced degrees in electrical engineering or biomedical engineering, experienced in electrosurgical techniques, signal design, and medical device development, familiar with emerging technologies in AI and IoT medical applications
Obviousness Rationale
A PHOSITA would recognize that integrating AI-driven pulse optimization, IoT monitoring, and advanced materials into tissue ablation represents a predictable technological evolution of the source patent's fundamental electroporation and pulse shape design principles. The core electrolysis and electroporation mechanisms remain consistent, with the PTD merely introducing contemporary technological augmentations that are well-established in medical device engineering. The systematic application of AI and IoT to optimize existing electrosurgical techniques would be considered an obvious extension of known technological improvement strategies.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,244 |
|---|---|
| Title | Methods, systems, and apparatuses for tissue ablation using pulse shape designs |
| Assignee(s) | RM2 TECHNOLOGY LLC, Inter Science GmbH |